-+ 0.00%
-+ 0.00%
-+ 0.00%

'Akeso Wins Chinese Approval For Cancer Drug Positioned To Rival Merck's Keytruda; Company Discloses Early Data Hinting At A Survival Benefit' - STAT News

Benzinga·04/25/2025 15:51:33
Listen to the news